CDC171: A Protein with Potential as A Drug Target Or Biomarker
CDC171: A Protein with Potential as A Drug Target Or Biomarker
CCDC171, also known as FLJ39267, is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the Flj1 gene family, which is known for its role in intracellular signaling.
CDC171 has been shown to play a role in a variety of physiological processes in the body, including cell signaling, neurodegeneration, and inflammation. Its expression has also been associated with a number of diseases, including neurodegenerative disorders, autoimmune diseases, and cancer.
One of the most promising aspects of CDC171 is its potential as a drug target. Researchers have identified several potential drug-like compounds that have been shown to interact with CDC171, and these compounds have been shown to have a variety of biological effects, including the inhibition of neurodegeneration and the regulation of inflammation.
In addition to its potential as a drug target, CDC171 has also been shown to be a valuable biomarker for a number of diseases. Its expression has been associated with a variety of diseases, including Alzheimer's disease, Parkinson's disease, and multiple sclerosis. The levels of CDC171 have also been used as a diagnostic marker for these diseases, with higher levels of CDC171 being associated with a more severe disease.
CDC171 is also a potential target for therapeutic intervention in a variety of other diseases, including cancer. Studies have shown that CDC171 is often overexpressed in a variety of cancer types, and that inhibition of its expression has the potential to be a therapeutic approach for cancer treatment.
Overall, CDC171 is a protein that has the potential to be a drug target or biomarker for a variety of diseases. Further research is needed to fully understand its role in these processes and to develop effective therapeutic approaches for the treatment of these diseases.
Protein Name: Coiled-coil Domain Containing 171
More Common Targets
CCDC172 | CCDC174 | CCDC175 | CCDC177 | CCDC178 | CCDC179 | CCDC18 | CCDC18-AS1 | CCDC180 | CCDC181 | CCDC182 | CCDC183 | CCDC183-AS1 | CCDC184 | CCDC185 | CCDC186 | CCDC187 | CCDC190 | CCDC191 | CCDC192 | CCDC194 | CCDC196 | CCDC197 | CCDC198 | CCDC200 | CCDC201 | CCDC22 | CCDC24 | CCDC25 | CCDC26 | CCDC27 | CCDC28A | CCDC28B | CCDC3 | CCDC30 | CCDC32 | CCDC33 | CCDC34 | CCDC38 | CCDC39 | CCDC40 | CCDC42 | CCDC43 | CCDC47 | CCDC50 | CCDC51 | CCDC54 | CCDC57 | CCDC6 | CCDC60 | CCDC61 | CCDC62 | CCDC63 | CCDC65 | CCDC66 | CCDC68 | CCDC69 | CCDC7 | CCDC70 | CCDC71 | CCDC71L | CCDC73 | CCDC74A | CCDC74B | CCDC77 | CCDC78 | CCDC8 | CCDC80 | CCDC81 | CCDC82 | CCDC83 | CCDC85A | CCDC85B | CCDC85C | CCDC86 | CCDC87 | CCDC88A | CCDC88B | CCDC88C | CCDC89 | CCDC9 | CCDC90B | CCDC91 | CCDC92 | CCDC92B | CCDC93 | CCDC96 | CCDC97 | CCDC9B | CCDST | CCEPR | CCER1 | CCER2 | CCHCR1 | CCIN | CCK | CCK receptor | CCKAR | CCKBR | CCL1